Charlotte A Gaydos1, Marcia Hobbs, Jeanne Marrazzo, Jane Schwebke, Jenell S Coleman, Billie Masek, Laura Dize, Dan Jang, Jenny Li, Max Chernesky. 1. From the *Division of Infectious Diseases, The Johns Hopkins University, Baltimore, MD; †Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC; ‡Division of Infectious Diseases, University of Washington, Seattle, WA; §Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL; and ¶Division of Infectious Diseases, St. Joseph's Healthcare/McMaster University, Hamilton, Ontario, Canada.
Abstract
BACKGROUND: The AmpliVue Trichomonas Assay (Quidel) is a new Federal Drug Administration-cleared rapid test for qualitative detection of Trichomonas vaginalis (TV) DNA in female vaginal specimens. The assay is based on BioHelix's helicase-dependent amplification isothermal technology in conjunction with a disposable lateral-flow detection device, with a total turnaround time of approximately 45 minutes. OBJECTIVE: The objective of this study was to compare the performance of this new assay to wet preparation and culture as well as to another Federal Drug Administration-cleared nucleic acid amplification assay. METHODS: Four clinician collected vaginal swabs were obtained from women attending sexually transmitted disease, family planning, and OB/GYN clinics and tested by AmpliVue Trichomonas Assay and comparator tests: saline microscopy, TV culture (InPouch), and Aptima TV. AmpliVue Trichomonas Assay results were compared with a composite positive comparator (CPC) as determined by the results from culture and/or wet mount microscopic examination. At least one of either the wet preparation or culture reference test results was required to be positive to establish CPC. RESULTS: A total of 992 patients, 342 symptomatic and 650 asymptomatic patients, were included in the study. Results for AmpliVue for all women combined compared with saline microscopy and culture as a CPC yielded a sensitivity of 100%. Specificity for all women was 98.2%. Overall percent agreement versus Aptima TV was 97.8%. Sensitivity for AmpliVue compared with Aptima was 90.7% %, whereas specificity was 98.9%. CONCLUSIONS: The rapid AmpliVue Trichomonas Assay performed as well as microscopy and culture, and had comparable sensitivity and specificity to another nucleic acid amplification test for the detection of TV. This study provided evidence of new diagnostic options and indicated very good performance of amplified testing for detection of TV in symptomatic and asymptomatic women.
BACKGROUND: The AmpliVue Trichomonas Assay (Quidel) is a new Federal Drug Administration-cleared rapid test for qualitative detection of Trichomonas vaginalis (TV) DNA in female vaginal specimens. The assay is based on BioHelix's helicase-dependent amplification isothermal technology in conjunction with a disposable lateral-flow detection device, with a total turnaround time of approximately 45 minutes. OBJECTIVE: The objective of this study was to compare the performance of this new assay to wet preparation and culture as well as to another Federal Drug Administration-cleared nucleic acid amplification assay. METHODS: Four clinician collected vaginal swabs were obtained from women attending sexually transmitted disease, family planning, and OB/GYN clinics and tested by AmpliVue Trichomonas Assay and comparator tests: saline microscopy, TV culture (InPouch), and Aptima TV. AmpliVue Trichomonas Assay results were compared with a composite positive comparator (CPC) as determined by the results from culture and/or wet mount microscopic examination. At least one of either the wet preparation or culture reference test results was required to be positive to establish CPC. RESULTS: A total of 992 patients, 342 symptomatic and 650 asymptomatic patients, were included in the study. Results for AmpliVue for all women combined compared with saline microscopy and culture as a CPC yielded a sensitivity of 100%. Specificity for all women was 98.2%. Overall percent agreement versus Aptima TV was 97.8%. Sensitivity for AmpliVue compared with Aptima was 90.7% %, whereas specificity was 98.9%. CONCLUSIONS: The rapid AmpliVue Trichomonas Assay performed as well as microscopy and culture, and had comparable sensitivity and specificity to another nucleic acid amplification test for the detection of TV. This study provided evidence of new diagnostic options and indicated very good performance of amplified testing for detection of TV in symptomatic and asymptomatic women.
Authors: Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos Journal: J Clin Microbiol Date: 2011-09-21 Impact factor: 5.948
Authors: C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos Journal: J Clin Microbiol Date: 2012-05-23 Impact factor: 5.948
Authors: James P Hughes; Jared M Baeten; Jairam R Lingappa; Amalia S Magaret; Anna Wald; Guy de Bruyn; James Kiarie; Mubiana Inambao; William Kilembe; Carey Farquhar; Connie Celum Journal: J Infect Dis Date: 2012-01-11 Impact factor: 5.226
Authors: Evelyn Byrd Quinlivan; Shilpa N Patel; Catherine A Grodensky; Carol E Golin; Hsiao-Chuan Tien; Marcia M Hobbs Journal: Sex Transm Dis Date: 2012-09 Impact factor: 2.830
Authors: Charles P Cartwright; Bryndon D Lembke; Kalpana Ramachandran; Barbara A Body; Melinda B Nye; Charles A Rivers; Jane R Schwebke Journal: J Clin Microbiol Date: 2013-08-28 Impact factor: 5.948
Authors: Brenna L Anderson; Cynthia Firnhaber; Tao Liu; Avril Swarts; Maureen Siminya; Jessica Ingersoll; Angela M Caliendo; Susan Cu-Uvin Journal: Sex Transm Dis Date: 2012-08 Impact factor: 2.830
Authors: Charlotte A Gaydos; Sajo Beqaj; Jane R Schwebke; Joel Lebed; Bonnie Smith; Thomas E Davis; Kenneth H Fife; Paul Nyirjesy; Timothy Spurrell; Dorothy Furgerson; Jenell Coleman; Sonia Paradis; Charles K Cooper Journal: Obstet Gynecol Date: 2017-07 Impact factor: 7.661
Authors: Charlotte A Gaydos; Jeffrey D Klausner; Nitika Pant Pai; Helen Kelly; Cordelia Coltart; Rosanna W Peeling Journal: Sex Transm Infect Date: 2017-07-06 Impact factor: 3.519
Authors: Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger Journal: Sex Transm Dis Date: 2019-05 Impact factor: 2.830
Authors: Andrew J Vallely; William S Pomat; Caroline Homer; Rebecca Guy; Stanley Luchters; Glen D L Mola; Grace Kariwiga; Lisa M Vallely; Virginia Wiseman; Chris Morgan; Handan Wand; Stephen J Rogerson; Sepehr N Tabrizi; David M Whiley; Nicola Low; Rosanna Peeling; Peter Siba; Michaela Riddell; Moses Laman; John Bolnga; Leanne J Robinson; Jacob Morewaya; Steven G Badman; Neha Batura; Angela Kelly-Hanku; Pamela J Toliman; Wilfred Peter; Delly Babona; Elizabeth Peach; Suzanne M Garland; John M Kaldor Journal: Wellcome Open Res Date: 2019-03-22
Authors: Giorgia Caruso; Anna Giammanco; Roberta Virruso; Teresa Fasciana Journal: Int J Environ Res Public Health Date: 2021-01-25 Impact factor: 3.390